Pediatric brain tumors have become the leading cause of cancer-related death in children. Significant advances in diagnosis and management have been made in recent years, and this volume encapsulates the latest developments in the field for various types of pediatric brain tumors. Additionally, this book addresses the stark disparities in outcomes for pediatric brain tumors in low- and middle-income countries (LMICs). By examining these survival gaps, the volume offers insights into strategies for improving outcomes and bridging the gap in care on a global scale. - State-of-the-Art Diagnostic Information: The book provides the most up-to-date diagnostic criteria for pediatric brain tumors, aligned with the latest CNS WHO classification - Cutting-Edge Advances in Targeted Therapy: Explore the latest breakthroughs in targeted therapies, offering new hope and precision in the treatment of pediatric brain tumors - Focus on Low- and Middle-Income Countries (LMICs): Gain insights into the unique challenges and innovative approaches to diagnosing and managing pediatric brain tumors in LMICs, aiming to bridge the gap in care and improve outcomes globally